(Washington, DC – May 19, 2016) – Galileo Analytics Co-Founder and CEO Simon Fitall will join a group of prestigious speakers at next week’s MD Bio+Tech16 conference in Bethesda, Maryland.
Fitall’s presentation will address the need to combine clinical care and out-patient data sources to truly understand health and disease. In addition, he will discuss the promise of tools, such as Galileo Cosmos, which enables researchers to dynamically explore these new, large, combined data sets to learn how to interpret these new data sources and extract the maximum value.
The Promise + Limits of Big Data
May 23, 2016
2:15 pm EDT
Katie Merrell, Senior Research Scientist, Social & Scientific Systems, Inc.
Simon Fitall, Co-Founder and Chief Executive Officer, Galileo Analytics
Dr. Nick van Terheyden, Chief Medical Officer, Dell Healthcare and Life Sciences
Michael Wasser, Founder and Chief Executive Officer, BloomAPI
About MD Bio+Tech16
MD Bio+Tech 16 is sponsored by the Tech Council of Maryland, which aims to build stronger technology and life science communities in Maryland by nurturing a healthy and vibrant environment where members can connect and prosper. Bio+Tech16 supports TCM’s mission by providing a forum for life science and technology professionals to exchange ideas and explore partnerships. In addition, Bio+Tech16 support TCM’s vision of positioning Maryland as a top-three innovation economy for technology and life sciences as well as the next “Silicon Valley” for these two industries.
For more information about MD Bio+Tech16, visit: http://bio-techconference.com